Vibe GrowthFRA:3ST0 +0.43%29 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates FRA:3ST0 with a GF Score™ of 29/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 685 Drug Manufacturers companies, Vibe Growth ranks worse than 91.82% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Vibe Growth's
Operating Income
for the
three
months ended in Mar. 2026 was €-0.02 Mil. Vibe Growth's Interest Expense for the
three
months ended in Mar. 2026 was €-0.03 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Vibe Growth Corp interest coverage is 1.13, which is low.
The historical rank and industry rank for Vibe Growth's Interest Coverage or its related term are showing as below:
FRA:3ST0'
s Interest Coverage Range Over the Past 10 Years
Min: 1.13 Med: 8.03 Max: 13.78
Current: 1.13
FRA:3ST0's Interest Coverage is ranked worse than 91.82% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs FRA:3ST0: 1.13
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Vibe Growth Interest Coverage Related Terms
Vibe Growth Interest Coverage Historical Data
* Premium members only.
The historical data trend for Vibe Growth's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Vibe Growth's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibe Growth Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vibe Growth's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Vibe Growth's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Vibe Growth did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Vibe Growth (FRA:3ST0) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vibe Growth and its competitors. Over the past decade, Vibe Growth's Interest Coverage has ranged from 1.13 to 13.78. According to the industry distribution chart, Vibe Growth ranks #629 out of 685 companies in the Drug Manufacturers industry, placing it in the top 91.8%.
Is Vibe Growth's Interest Coverage too high?
Vibe Growth's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 13.78. Based on the distribution chart, Vibe Growth ranks #629 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vibe Growth has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vibe Growth's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vibe Growth ranks #629 out of 685 companies for Interest Coverage. This places Vibe Growth in the lower half of its industry. The industry median Interest Coverage is 12.78. Historically, Vibe Growth's own Interest Coverage has ranged from 1.13 to 13.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vibe Growth and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibe Growth's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibe Growth stock overvalued right now?
Based on GuruFocus' analysis, Vibe Growth (FRA:3ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.23 — trading 191.3% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Vibe Growth's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Vibe Growth (FRA:3ST0), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibe Growth (FRA:3ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Vibe Growth stock appears to be overvalued.
The current stock price of €0.23 is trading 191.3% above its estimated GF Value™ of €0.08.
GuruFocus considers Vibe Growth to be Significantly Overvalued.
Key valuation signals for FRA:3ST0:
Interest Coverage: 0 (At Loss)
GF Value™: €0.08 vs. price of €0.23 (191.3% above fair value)
No single metric tells the full story. See the FRA:3ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibe Growth Corp is engaged in the evaluation, acquisition, and development of cannabis cultivation, distribution, and manufacturing assets and retail cannabis dispensaries, predominantly in the U.S., to become a vertically integrated cannabis operator. The company currently operates four dispensaries, one distribution, and one cultivation operation in the State of California, plus one dispensary in Portland, Oregon. It offers cannabis infused products across various categories such as vaporizers, concentrates, edibles, topicals, pre-rolls, etc., and through different brands including Alien Labs, Almora Farm, Buddies, Chill Bud, Highatus, and Others.
29GF Score
Get the complete analysis for FRA:3ST0
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3ST0 has been successfully added to your 
